G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes - PubMed (original) (raw)

. 2005 Nov;19(11):2760-8.

doi: 10.1210/me.2004-0429. Epub 2005 Jun 30.

Affiliations

• PMID: 15994203
• DOI: 10.1210/me.2004-0429

G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes

Isao Usui et al. Mol Endocrinol. 2005 Nov.

Abstract

G protein-coupled receptor kinases (GRKs) regulate seven-transmembrane receptors (7TMRs) by phosphorylating agonist-activated 7TMRs. Recently, we have reported that GRK2 can function as a negative regulator of insulin action by interfering with G protein-q/11 alpha-subunit (Galphaq/11) signaling, causing decreased glucose transporter 4 (GLUT4) translocation. We have also reported that chronic endothelin-1 (ET-1) treatment leads to heterologous desensitization of insulin signaling with decreased tyrosine phosphorylation of insulin receptor substrate (IRS)-1 and Galphaq/11, and decreased insulin-stimulated glucose transport in 3T3-L1 adipocytes. In the current study, we have investigated the role of GRK2 in chronic ET-1-induced insulin resistance. Insulin-induced GLUT4 translocation was inhibited by pretreatment with ET-1 for 24 h, and we found that this inhibitory effect was rescued by microinjection of anti-GRK2 antibody or GRK2 short interfering RNA. We further found that GRK2 mediates the inhibitory effects of ET-1 by two distinct mechanisms. Firstly, adenovirus-mediated overexpression of either wild-type (WT)- or kinase-deficient (KD)-GRK2 inhibited Galphaq/11 signaling, including tyrosine phosphorylation of Galphaq/11 and cdc42-associated phosphatidylinositol 3-kinase activity. Secondly, ET-1 treatment caused Ser/Thr phosphorylation of IRS-1 and IRS-1 protein degradation. Overexpression of KD-GRK2, but not WT-GRK2, inhibited ET-1-induced serine 612 phosphorylation of IRS-1 and restored activation of this pathway. Taken together, these results suggest that GRK2 mediates ET-1-induced insulin resistance by 1) inhibition of Galphaq/11 activation, and this effect is independent of GRK2 kinase activity, and 2) GRK2 kinase activity-mediated IRS-1 serine phosphorylation and degradation.

PubMed Disclaimer

Similar articles

• Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
  Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM. Ishibashi KI, et al. J Clin Invest. 2001 May;107(9):1193-202. doi: 10.1172/JCI11753. J Clin Invest. 2001. PMID: 11342583 Free PMC article.
• GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation.
  Usui I, Imamura T, Satoh H, Huang J, Babendure JL, Hupfeld CJ, Olefsky JM. Usui I, et al. EMBO J. 2004 Jul 21;23(14):2821-9. doi: 10.1038/sj.emboj.7600297. Epub 2004 Jul 8. EMBO J. 2004. PMID: 15241473 Free PMC article.
• Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
  Li Q, Hosaka T, Shikama Y, Bando Y, Kosugi C, Kataoka N, Nakaya Y, Funaki M. Li Q, et al. Endocrinology. 2012 Jan;153(1):56-68. doi: 10.1210/en.2011-1418. Epub 2011 Oct 25. Endocrinology. 2012. PMID: 22028447
• [The expression of the insulin receptor substrate-1 (IRS-1) and analysis of its mechanism].
  Shichiri M, Araki E. Shichiri M, et al. Nihon Naibunpi Gakkai Zasshi. 1995 Jan 20;71(1):21-6. doi: 10.1507/endocrine1927.71.1_21. Nihon Naibunpi Gakkai Zasshi. 1995. PMID: 7895862 Review. Japanese.
• Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling.
  Le Marchand-Brustel Y, Gual P, Grémeaux T, Gonzalez T, Barrès R, Tanti JF. Le Marchand-Brustel Y, et al. Biochem Soc Trans. 2003 Dec;31(Pt 6):1152-6. doi: 10.1042/bst0311152. Biochem Soc Trans. 2003. PMID: 14641015 Review.

Cited by

• G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms.
  Santulli G, Trimarco B, Iaccarino G. Santulli G, et al. High Blood Press Cardiovasc Prev. 2013 Mar;20(1):5-12. doi: 10.1007/s40292-013-0001-8. Epub 2013 Mar 27. High Blood Press Cardiovasc Prev. 2013. PMID: 23532739 Review.
• Insulin signalling mechanisms for triacylglycerol storage.
  Czech MP, Tencerova M, Pedersen DJ, Aouadi M. Czech MP, et al. Diabetologia. 2013 May;56(5):949-64. doi: 10.1007/s00125-013-2869-1. Epub 2013 Feb 27. Diabetologia. 2013. PMID: 23443243 Free PMC article. Review.
• Role of G protein-coupled receptor kinases (GRKs) in β2 -adrenoceptor-mediated glucose uptake.
  Ham S, Mukaida S, Sato M, Keov P, Bengtsson T, Furness S, Holliday ND, Evans BA, Summers RJ, Hutchinson DS. Ham S, et al. Pharmacol Res Perspect. 2024 Feb;12(1):e1176. doi: 10.1002/prp2.1176. Pharmacol Res Perspect. 2024. PMID: 38332691 Free PMC article.
• Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats.
  Xing W, Li Y, Zhang H, Mi C, Hou Z, Quon MJ, Gao F. Xing W, et al. Am J Physiol Heart Circ Physiol. 2013 Oct 15;305(8):H1111-9. doi: 10.1152/ajpheart.00290.2013. Epub 2013 Aug 2. Am J Physiol Heart Circ Physiol. 2013. PMID: 23913704 Free PMC article.
• Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.
  Morino K, Petersen KF, Shulman GI. Morino K, et al. Diabetes. 2006 Dec;55 Suppl 2(Suppl 2):S9-S15. doi: 10.2337/db06-S002. Diabetes. 2006. PMID: 17130651 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • PhosphoSitePlus

• Miscellaneous

  • NCI CPTAC Assay Portal